Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutshland GmbH
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Mylan Pharmaceuticals Inc.
Patent Owner:
Sanofi-Aventis Deutshland GmbH
Tech Center:
3700
-
April 06, 2020
Mylan Gets PTAB To Nix Sanofi's Lantus Patent Claim
Mylan has successfully persuaded the Patent Trial and Appeal Board that one claim of a Sanofi-Aventis patent covering the Lantus SoloStar disposable insulin injection pen is invalid as obvious.
-
January 15, 2020
PTAB Weighs Sanofi Insulin Pen Patents In Mylan IP Row
The Patent Trial and Appeal Board asked tough questions about the role of injection force during six consolidated inter partes reviews Wednesday in Mylan's effort to knock out several Sanofi-Aventis patents covering the Lantus SoloStar disposable insulin injection pen.